Charles Schwab Investment Management Inc Rocket Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 656,090 shares of RCKT stock, worth $4.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
656,090
Previous 569,814
15.14%
Holding current value
$4.98 Million
Previous $10.5 Million
21.64%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding RCKT
# of Institutions
242Shares Held
94.3MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$134 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$49.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$47 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$39.5 Million1.26% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$35.8 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $574M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...